Thomas R. Viggiano

Mayo Clinic Proceedings and Steatohepatitis: From NASH Recognition to MASH Therapy

Hanna L Erickson, Thomas R. Viggiano, Harmeet Malhi

us (code pays fourni par la source)

Reflecting on Progress in and Establishing Benchmarks for Sex and Gender Health Education

Elizabeth Barr, Eliza Lo Chin, Connie B. Newman, Mary K. Rojek et autres

ABSTRACT: Sex and gender influence every aspect of human health; thus, sex- and gender-related topics should be incorporated in all aspects of health education curricula. Sex and gender health education (SGHE) is the rigorous, intersectional, data-driven integration of sex and gender into …

us (code pays fourni par la source)

A NOVEL SWALLOWED BLOOD-SENSING CAPSULE FOR DETECTION OF UPPER GASTROINTESTINAL HEMORRHAGE: A PROSPECTIVE BLINDED CLINICAL TRIAL

Karl Akiki, Tala Mahmoud, Mohammad H. Alqaisieh, Lea Nicole Sayegh et autres

Data from Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia

Frank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song et autres

Abstract Polyphenon E (Poly E) is a green tea polyphenol preparation whose most active component is epigallocatechin gallate (EGCG). We studied the cancer preventive efficacy and safety of Poly E in subjects with rectal aberrant crypt foci (ACF), which represent putative precursors …

Supplementary Table from Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia

Frank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song et autres

Supplementary Table 1

Supplementary Table from Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia

Frank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song et autres

Supplementary Table 1

Data from Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia

Frank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song et autres

Abstract Polyphenon E (Poly E) is a green tea polyphenol preparation whose most active component is epigallocatechin gallate (EGCG). We studied the cancer preventive efficacy and safety of Poly E in subjects with rectal aberrant crypt foci (ACF), which represent putative precursors …

Acute Esophageal Necrosis: A Retrospective Cohort Study Highlighting the Mayo Clinic Experience

Anthony Robateau Colón, Amrit K. Kamboj, Catherine E. Hagen, Puru Rattan et autres

us (code pays fourni par la source)

A Quality Improvement Management Model for Curriculum Evaluation and Integration

Thomas R. Viggiano

Only one student from each class served on the Organ System Curriculum Committee. Thus, students were only marginally involved in curriculum management. It was in this context that a system was developed for students to apply continuous quality improvement principles to curriculum …

Randomized Phase II Trial of Polyphenon E versus Placebo in Patients at High Risk of Recurrent Colonic Neoplasia

Frank A. Sinicrope, Thomas R. Viggiano, Navtej S. Buttar, Louis M. Wong Kee Song et autres

Abstract Polyphenon E (Poly E) is a green tea polyphenol preparation whose most active component is epigallocatechin gallate (EGCG). We studied the cancer preventive efficacy and safety of Poly E in subjects with rectal aberrant crypt foci (ACF), which represent putative precursors …

us, hu (code pays fourni par la source)

Efficacy of Difluoromethylornithine and Aspirin for Treatment of Adenomas and Aberrant Crypt Foci in Patients with Prior Advanced Colorectal Neoplasms

Frank A. Sinicrope, Pruthvi Raj Velamala, Louis M. Wong Kee Song, Thomas R. Viggiano et autres

Abstract Difluoromethylornithine (DFMO), an inhibitor of polyamine synthesis, was shown to act synergistically with a NSAID for chemoprevention of colorectal neoplasia. We determined the efficacy and safety of DFMO plus aspirin for prevention of colorectal adenomas and regression of rectal aberrant crypt …

us (code pays fourni par la source)

470 - Randomized Placebo-Controlled Trial of Difluoromethylornithine (DFMO) Plus Aspirin for the Prevention of Colorectal Adenoma Recurrence and Reduction in Aberrant Crypt Foci (ACF) in Patients with Prior Advanced Adenomas or Cancer

Frank A. Sinicrope, Pruthvi Raj Velamala, Louis M. Wong Kee Song, Thomas R. Viggiano et autres